Related Experiment Videos
[p53 mutation in phenacetin-induced urothelial carcinomas]
I Petersen1, H Ohgaki, B I Ludeke
1Institut für Neuropathologie, Departement Pathologie, Zürich.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|January 1, 1993
Summary
Phenacetin abuse is linked to urothelial carcinomas, with p53 mutations found in 57% of tumors. This suggests chronic tissue damage, not direct DNA damage, causes these cancers.
Area of Science:
- Oncology
- Molecular Biology
- Toxicology
Context:
- Phenacetin, a widely used analgesic, has been anecdotally linked to urothelial carcinoma.
- The precise mechanism by which phenacetin may induce cancer remains unclear.
Purpose:
- To investigate the presence and spectrum of p53 mutations in urothelial carcinomas associated with phenacetin abuse.
- To elucidate the potential role of chronic tissue damage versus direct DNA damage in phenacetin-induced carcinogenesis.
Summary:
- p53 mutations were identified in 8 of 14 (57%) primary urothelial carcinomas from patients with phenacetin abuse.
- Mutations included missense alterations in exons 5-8 and a single cytosine insertion in exon 5.
- Independent tumor development and intracavitary metastasis were suggested by distinct or identical p53 mutations in different tumor locations.
Impact:
- Findings support the hypothesis that phenacetin induces urothelial carcinomas via chronic tissue damage.
- This research contributes to understanding the pathogenesis of analgesic-associated bladder cancers.
- Highlights the importance of considering environmental and lifestyle factors in cancer etiology.